| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-B-DIST | DEUDA PRIVADA EMERGENTES HRD CCY | 783,031965 | 26/08/2026 | 1,41% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 144,759620 | 26/08/2026 | 0,99% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-DIST | DEUDA PRIVADA EMERGENTES HRD CCY | 812,957409 | 26/08/2026 | 0,99% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND P-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 135,015854 | 26/08/2026 | 0,66% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND Q-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 115,271231 | 26/08/2026 | 0,93% | · | ND |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) P-ACC | RVI BIOTECNOLOGÍA | 975,251181 | 27/08/2026 | 29,13% | 57,24% | *** |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) Q-ACC | RVI BIOTECNOLOGÍA | 442,241305 | 27/08/2026 | 30,00% | 62,15% | *** |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) QL-ACC | RVI BIOTECNOLOGÍA | 144,439674 | 27/08/2026 | 30,17% | 63,12% | *** |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) P-ACC | RVI CHINA | 81,740000 | 27/08/2026 | -8,39% | 12,16% | * |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) Q-ACC | RVI CHINA | 66,820000 | 27/08/2026 | -7,71% | 15,77% | * |
